Skip to main content
EQL Pharma AB logo

EQL Pharma AB — Investor Relations & Filings

Ticker · EQL ISIN · SE0005497732 LEI · 549300Q8B2D2AE8GCW21 ST Manufacturing
Open in API
Filings indexed 57 across all filing types
Latest filing 2025-05-08 Interim / Quarterly Rep…
Country SE Sweden
Listing ST EQL

About EQL Pharma AB

https://eqlpharma.com/en/

EQL Pharma AB is a pharmaceutical company that develops, markets, and sells generic and specialty medicines. The company's strategy centers on identifying and developing "niche generics," which are medically equivalent to originator drugs but face limited competition after patent expiration. Its business operations also include specialty pharmaceuticals and the parallel import of medicines. EQL Pharma emphasizes cost-efficiency and collaborates with a global network of development partners. The company serves pharmacies and hospitals, primarily in the Nordic markets, maintaining a portfolio of marketed products while cultivating an extensive pipeline of new medicines.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document contains detailed financial tables including Net sales, Gross profit, EBITDA, and Operating profit for the period Jan-Mar 2025 compared to Jan-Mar 2024. Although the text mentions 'Year-End Report' in a table header, the data provided is clearly for a quarterly period (Jan-Mar), which classifies it as an Interim/Quarterly Report. It contains substantive financial data, satisfying the requirement for an IR classification rather than an announcement. Q1 2025
2025-05-08 English
New financial targets for the period 2024/25 – 2028/29
Report Publication Announcement Classification · 1% confidence The document is a press release announcing new financial targets for the period 2024/25 – 2028/29, including specific CAGR, EBITDA margin goals, and leverage targets. It also mentions that these targets will be presented in detail at the company's Capital Markets Day. Since it is an announcement of future financial strategy and targets, it is not a full Annual Report (10-K), an Interim Report (IR), or a standard Earnings Release (ER) which typically reports past performance. It is a strategic update aimed at investors. While it relates to investor information, it is not a formal Investor Presentation (IP) or a Management Discussion & Analysis (MDA). Given the context of setting future financial goals and strategy, and the fact that it is a press release format, it most closely aligns with a general strategic update. However, none of the codes perfectly capture a 'Financial Target Setting Press Release'. Since it details financial performance expectations and strategy, it is closest to an Investor Presentation (IP) in content focus, but the format is a press release. Given the options, and recognizing that this is a strategic financial update, it is often grouped with investor materials. If it were a short announcement linking to a detailed presentation, it would be RPA. Since it contains the core targets itself, it functions as a high-level strategic disclosure. In the absence of a specific 'Strategy Update' code, and noting that it is not a formal regulatory filing like 10-K or IR, I will classify it based on its content focus on future financial performance and strategy, which is often the core of an Investor Presentation (IP). However, the document explicitly states the full presentation will be available later, suggesting this press release is the initial announcement. This initial announcement of strategic financial goals is often categorized under general investor communications. Given the options, and the focus on future financial metrics, IP is the best fit among the specific choices, although RPA might also be considered if the document were shorter and only pointed to the CMD. Since it contains the substance, IP is chosen over RPA.
2025-03-07 English
Nya finansiella mål för perioden 2024/25 - 2028/29
Earnings Release Classification · 1% confidence The document is a press release dated March 7, 2025, announcing new financial targets (revenue growth CAGR, EBITDA margin target, and debt ratio goals) for the period 2024/25 to 2028/29, following the conclusion of a previous 5-year plan. It explicitly mentions that these goals will be presented in detail at the company's Capital Markets Day later that day. Since the document itself is an announcement setting out future financial guidance and strategy, and not the detailed presentation (IP) or a comprehensive periodic report (IR/10-K), it best fits the category for initial financial result announcements or strategic updates. Given the focus on setting future financial targets and strategy, it aligns closely with an Earnings Release (ER) which often includes forward-looking guidance, or potentially an Investor Presentation (IP) if it were the presentation itself. However, as a short press release announcing the *new goals* and referencing a presentation later that day, it functions as an initial financial update. Since it is not a formal quarterly/interim report (IR) or the full presentation (IP), and it contains key financial metrics/targets, 'ER' (Earnings Release) is the most appropriate fit for an initial financial guidance announcement, although 'IP' (Investor Presentation) is also plausible if the guidance is considered strategic material. Given the structure as a 'Pressmeddelande' announcing financial targets, ER is selected as the primary classification for initial financial guidance releases. FY 2025
2025-03-07 Swedish
Valberedning inför årsstämman 2025
Board/Management Information Classification · 1% confidence The document is a press release dated February 24, 2025, concerning the 'Valberedning inför årsstämman 2025' (Nomination Committee for the Annual General Meeting 2025). It details the composition of the nomination committee based on shareholder representation ahead of the AGM. This content directly relates to the governance and preparatory materials for the Annual General Meeting (AGM). While it is not the AGM presentation itself (AGM-R) or the proxy statement (PSI), it is a specific announcement regarding the governance structure leading up to the meeting. Given the options, this type of announcement about the composition of the committee responsible for nominating board members for the AGM is most closely related to AGM Information (AGM-R) or Governance Information (CGR). Since it specifically names the committee for the upcoming AGM, AGM-R is the most appropriate fit, as it concerns materials/information related to the AGM process.
2025-02-24 Swedish
Nomination committee for the 2025 Annual General Meeting
AGM Information Classification · 1% confidence The document is a press release dated February 24th, 2025, titled 'Nomination committee for the 2025 Annual General Meeting'. It details the composition of the Nomination Committee responsible for proposing candidates for the upcoming Annual General Meeting (AGM). This content directly relates to the preparatory materials and governance structure surrounding the AGM, fitting the definition of 'AGM Information' (AGM-R). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (PSI), but specifically concerns the AGM nomination process.
2025-02-24 English
Interim / Quarterly Report 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport' (Interim Report in Swedish) and contains detailed financial tables including net sales, gross profit, and EBIT for the period of October-December 2024 and April-December 2024. It provides substantive financial data and analysis rather than just an announcement or certification. Therefore, it is classified as an Interim/Quarterly Report. 9M 2025
2025-02-05 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.